2009
DOI: 10.1016/j.jdiacomp.2007.09.001
|View full text |Cite
|
Sign up to set email alerts
|

The effects of sulfonylurea glyburide on superoxide dismutase, catalase, and glutathione peroxidase activities in the brain tissue of streptozotocin-induced diabetic rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
14
1

Year Published

2009
2009
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(18 citation statements)
references
References 36 publications
3
14
1
Order By: Relevance
“…These observations, except in body weight gain, were in accordance with results of Barbera et al [15]. Brain is one of the organs which consumes the greatest amount of oxygen in the body and has the highest polyunsaturated fatty acid and the lowest level of protective antioxidant (CAT and GPX) [31,32]. Therefore, this organ is more vulnerable to damage in conditions that increase free radical production.…”
Section: Discussionsupporting
confidence: 91%
“…These observations, except in body weight gain, were in accordance with results of Barbera et al [15]. Brain is one of the organs which consumes the greatest amount of oxygen in the body and has the highest polyunsaturated fatty acid and the lowest level of protective antioxidant (CAT and GPX) [31,32]. Therefore, this organ is more vulnerable to damage in conditions that increase free radical production.…”
Section: Discussionsupporting
confidence: 91%
“…This argues against dramatic destructive effects of the drug on β cell mass. Moreover, it has been shown that under diabetic conditions, sulfonylureas influence the activities of antioxidant enzymes: brain SOD and Cat activities are reduced in rats with STZ-induced diabetes, but the decrease in antioxidant status is reversed by glibenclamide treatment (56). According to the current concept, protection against β cell death is attributed to K ATP channel openers (KCOs) instead of channel blockers.…”
Section: Discussionmentioning
confidence: 99%
“…Modulation of antioxidant status during therapy with sulfonylureas has been described for pancreatic tissue and for heart, liver, and brain of STZ-diabetic rats where diabetes-induced alterations in enzyme activity were normalised after 4-5 weeks of glibenclamide treatment [186][187][188]. In addition, serum antioxidant capacity and SOD activity significantly increased in type 2 diabetic patients treated with the K ATP channel inhibitor repaglinide [189].…”
Section: Strategies Targeting Ros or Rns Formation In Beta-cells Cumentioning
confidence: 97%